Literature DB >> 26414751

Plasma Cytokine Levels in Chronic Asymptomatic HIV-1 Subtype C Infection as an Indicator of Disease Progression in Botswana: A Retrospective Case Control Study.

Thato Iketleng1,2, Sikhulile Moyo1, Simani Gaseitsiwe1,3, Balthazar Nyombi2, Rebecca M Mitchell4, Joseph Makhema1,3, Marianna K Baum5, Richard Marlink1,3, Max Essex1,3, Rosemary Musonda1,3.   

Abstract

HIV infects cells of the immune system causing immune activation and proliferation of immune cells, leading to alteration of production and activity of a number of cytokines. These changes in cytokine levels can affect the immune function, and have the potential to directly impact the course of HIV disease. We characterized plasma cytokine concentration profiles in HIV-1 subtype C chronically infected, antiretroviral therapy (ART)-naive participants to establish their influence on disease progression and viremia. Plasma levels of interleukin (IL)-1α, IL-7, IL-12p40, granulocyte macrophage-colony-stimulating factor (GM-CSF), and interferon (IFN)-γ were quantified in samples from 60 treatment-naive participants in the placebo arm of the completed Micronutrient-HIV disease progressions study, "Dikotlana" (2004-2009) in Gaborone, Botswana. Participants were stratified into progressors (P) and nonprogressors (NP) based on their rates of CD4(+) T cell depletion during the study period. Nonprogressors were those who had <1% CD4(+) T cell depletion at 24 months postenrollment. Progressors were defined as those with CD4(+) T cell depletion of >15% at 24 months postenrollment. Cytokine levels were compared between P and NP using the Mann-Whitney U-test. Logistic regression analysis was used to determine if cytokines predicted disease progression. Correlations of cytokines with CD4(+) T cell counts and viral loads were determined by the Spearman rank test. Median baseline CD4(+) T cell counts were 453 (Q1, Q3; 401, 592) and 479 (Q1, Q3; 401-592) for nonprogressors and progressors, respectively. Nonprogressors had a higher viral set point than progressors. IL-12p40 levels were significantly higher in the P than in NP at enrollment and 24 months (p < 0.05). Levels of IL-1α, IL-7, IFN-γ, and GM-CSF did not differ significantly between the two groups. Except for IL-12p40, which displayed an inverse correlation with CD4(+) T cell counts and a direct correlation with viral load, all other cytokines showed no correlations. IL-12p40 was found to be the most significant predictor of progression and its production was most likely driven by HIV replication products as evidenced by its direct correlation with viral load. In chronic HIV-1 subtype C infection, CD4(+) T cell counts and plasma cytokine levels may not necessarily evolve in parallel, suggesting the involvement of other factors in determining the rates of CD4(+) T cell depletion.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26414751      PMCID: PMC5220552          DOI: 10.1089/AID.2015.0163

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  20 in total

1.  Ongoing changes in HIV RNA levels during untreated HIV infection: implications for CD4 cell count depletion.

Authors:  Andrew N Phillips; Fiona C Lampe; Colette J Smith; Anna-Maria Geretti; Alison Rodger; Rebecca K Lodwick; Valentina Cambiano; Robert Tsintas; Margaret A Johnson
Journal:  AIDS       Date:  2010-06-19       Impact factor: 4.177

2.  Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression.

Authors:  Lindi Roberts; Jo-Ann S Passmore; Carolyn Williamson; Francesca Little; Lisa M Bebell; Koleka Mlisana; Wendy A Burgers; Francois van Loggerenberg; Gerhard Walzl; Joel F Djoba Siawaya; Quarraisha Abdool Karim; Salim S Abdool Karim
Journal:  AIDS       Date:  2010-03-27       Impact factor: 4.177

3.  Role of chemokine and cytokine polymorphisms in the progression of HIV-1 disease.

Authors:  Supriya D Mahajan; Anardi Agosto-Mojica; Ravikumar Aalinkeel; Jessica L Reynolds; Bindukumar B Nair; Donald E Sykes; Jeffery Martinez; Joshua Adams; Neha Singh; Zale Bernstein; Chiu-bin Hsiao; Stanley A Schwartz
Journal:  Biochem Biophys Res Commun       Date:  2010-04-21       Impact factor: 3.575

4.  Effect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naive, HIV-infected adults in Botswana: a randomized clinical trial.

Authors:  Marianna K Baum; Adriana Campa; Shenghan Lai; Sabrina Sales Martinez; Lesedi Tsalaile; Patricia Burns; Mansour Farahani; Yinghui Li; Erik van Widenfelt; John Bryan Page; Hermann Bussmann; Wafaie W Fawzi; Sikhulele Moyo; Joseph Makhema; Ibou Thior; Myron Essex; Richard Marlink
Journal:  JAMA       Date:  2013-11-27       Impact factor: 56.272

Review 5.  Pro- and anti-inflammatory cytokines in human immunodeficiency virus infection and acquired immunodeficiency syndrome.

Authors:  Elizabeth Crabb Breen
Journal:  Pharmacol Ther       Date:  2002-09       Impact factor: 12.310

6.  High systemic levels of interleukin-10, interleukin-22 and C-reactive protein in Indian patients are associated with low in vitro replication of HIV-1 subtype C viruses.

Authors:  Juan F Arias; Reiko Nishihara; Manju Bala; Kazuyoshi Ikuta
Journal:  Retrovirology       Date:  2010-03-09       Impact factor: 4.602

Review 7.  Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm.

Authors:  Emily S Ford; Camille E Puronen; Irini Sereti
Journal:  Curr Opin HIV AIDS       Date:  2009-05       Impact factor: 4.283

Review 8.  The biology of IL-12: coordinating innate and adaptive immune responses.

Authors:  Wendy T Watford; Masato Moriguchi; Akio Morinobu; John J O'Shea
Journal:  Cytokine Growth Factor Rev       Date:  2003-10       Impact factor: 7.638

9.  Regulation of interleukin 12 p40 and p70 production by blood and alveolar phagocytes during severe sepsis.

Authors:  Frédéric Ethuin; Charlotte Delarche; Marie-Anne Gougerot-Pocidalo; Benoît Eurin; Laurent Jacob; Sylvie Chollet-Martin
Journal:  Lab Invest       Date:  2003-09       Impact factor: 5.662

Review 10.  Cytokines and HIV-1: interactions and clinical implications.

Authors:  K Kedzierska; S M Crowe
Journal:  Antivir Chem Chemother       Date:  2001-05
View more
  2 in total

1.  Distinct biomarker signatures in HIV acute infection associate with viral dynamics and reservoir size.

Authors:  Jeffrey E Teigler; Louise Leyre; Nicolas Chomont; Bonnie Slike; Ningbo Jian; Michael A Eller; Nittaya Phanuphak; Eugène Kroon; Suteeraporn Pinyakorn; Leigh Anne Eller; Merlin L Robb; Jintanat Ananworanich; Nelson L Michael; Hendrik Streeck; Shelly J Krebs
Journal:  JCI Insight       Date:  2018-05-17

2.  Inhibition of p38 MAPK in combination with ART reduces SIV-induced immune activation and provides additional protection from immune system deterioration.

Authors:  Omkar Chaudhary; Vivek Narayan; Felipe Lelis; Brandon Linz; Meagan Watkins; Ronald Veazey; Anna Aldovini
Journal:  PLoS Pathog       Date:  2018-08-30       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.